Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel bisaryl substituted catalyst enables high stereoselectivity. Reduces manufacturing costs and ensures supply chain reliability for complex pharmaceutical intermediate production.
Discover the ligand-assisted zirconium oxychloride method for amide preparation. A cost-effective, scalable solution for high-purity pharmaceutical intermediates.
Patent CN105085189A details a robust aprotic solvent method for chiral alcohol synthesis, offering significant supply chain stability and cost reduction for pharmaceutical intermediates.
Patent CN113980053A discloses novel chiral thioether-phosphine ligands enabling efficient palladium-catalyzed asymmetric allylic alkylation with high yields.
Green synthesis process for high-purity fluoroquinolone intermediates via patent CN110407735B. Reduces energy consumption and enables continuous industrial production.
Novel ionic liquid catalysis for 4H-benzo[b]pyran derivatives ensures high purity and cost-effective manufacturing for pharmaceutical intermediates globally.
Patent CN116102517B reveals a one-step synthesis method offering high purity and reduced toxicity for reliable agrochemical intermediate supply chains.
Patent CN119530189A reveals green enzymatic route for cyclohexylamine. Offers high selectivity and reduced environmental impact for pharmaceutical intermediate supply chains.
Patent CN101525291A details a water-based organocatalytic route for chiral bicyclics, offering high enantioselectivity and reduced environmental impact for pharmaceutical manufacturing.
Patent CN106146459A reveals a cost-effective Bilastine synthesis. Enhances supply chain reliability and reduces manufacturing complexity for global pharmaceutical partners.
Patent CN104496749B reveals a high-selectivity method for substituted cinnamyl alcohol using nanoporous gold. Offers cost reduction and supply reliability for pharmaceutical intermediates.
Novel antimony chloride catalyzed route for 4-hydroxyaurone compounds ensuring high purity and scalable production for global pharmaceutical supply chains.
Patent CN103922934A reveals cost-effective inorganic alkali alkylation. Enhances supply chain reliability and reduces manufacturing costs for intermediates.
Patent CN112063531B reveals a novel Geotrichum candidum strain for Ticagrelor intermediate synthesis, offering high stereoselectivity and reduced manufacturing costs.
Novel Lewis base catalyzed route offers high purity pharmaceutical intermediates with streamlined supply chain and cost efficiency for global buyers.
Patent CN101654422A reveals a hydrazine-based reduction route for 3,3'-DDS, offering high purity and reduced waste for polymer and epoxy applications.
Patent CN121517422A reveals mixed acid catalysis for high-purity hexacyclopropyl hexaazaisowurtzitane. Enhances safety and yield for pharmaceutical intermediate manufacturing.
Novel 5-step synthesis route for chiral phenylglycine catalysts. High yield, mild conditions, scalable for pharma intermediates.
Patent CN109706189B reveals enzymatic route for D-chiro-inositol. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel recombinant (R)-ω-transaminase mutant enables high-yield sitagliptin production with superior stereoselectivity and enzyme activity for pharmaceutical supply chains.